Jeil Pharmaceutical Co.,Ltd (KRX:271980)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,640
-210 (-1.63%)
At close: Jun 5, 2025, 3:30 PM KST
-20.60%
Market Cap 184.18B
Revenue (ttm) 697.15B
Net Income (ttm) -24.47B
Shares Out 14.57M
EPS (ttm) -1,680.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 35,044
Average Volume 54,122
Open 12,830
Previous Close 12,850
Day's Range 12,630 - 12,940
52-Week Range 10,120 - 16,990
Beta 0.89
RSI 51.15
Earnings Date May 15, 2025

About KRX:271980

Jeil Pharmaceutical Co.,Ltd develops and supplies pharmaceutical products primarily in South Korea. It provides products in the areas of antibiotic, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamine. The company also exports its products to approximately 40 countries in ASEAN, Central and South America, Africa, and internationally. Jeil Pharmaceutical Co.,Ltd was founded in 1959 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1959
Employees 943
Stock Exchange Korea Stock Exchange
Ticker Symbol 271980
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.